Bellevue Asset Management AG 13F 持仓 · 最近申报 2015年Q4
Bellevue Asset Management 在 2015年Q4（报告期截至 2015-12-31）的 SEC 13F 申报中报告了 127 只证券，申报市值合计 6.56 亿美元。前几大持仓：CELG（3.97%）、BIIB（3.92%）、GILD（3.70%）。本季前 25 大持仓中：新建仓 1 只、增持 12 只、减持 7 只。
| 排名 | 代码 | 公司 | 市值 | 占组合 | 股数 | 变动 |
|---|---|---|---|---|---|---|
| 1 | CELG | Celgene Corporation | $26.0M | 3.97% | 217,410 | 减持 |
| 2 | BIIB | Biogen Inc. | $25.7M | 3.92% | 84,030 | 增持 |
| 3 | GILD | Gilead Sciences, Inc. | $24.3M | 3.70% | 240,120 | 减持 |
| 4 | AMGN | Amgen Inc. | $20.0M | 3.04% | 123,000 | 增持 |
| 5 | MDT | Medtronic, Inc. | $19.7M | 3.01% | 256,500 | 减持 |
| 6 | REGN | Regeneron Pharmaceuticals, Inc. | $19.8M | 3.01% | 36,400 | 减持 |
| 7 | ILMN | Illumina, Inc. | $17.5M | 2.67% | 91,425 | 增持 |
| 8 | ABT | Abbott Laboratories | $17.1M | 2.61% | 381,500 | 减持 |
| 9 | VTRS | Mylan Inc. | $17.0M | 2.60% | 315,300 | 增持 |
| 10 | BDX | Becton, Dickinson and Company | $16.2M | 2.47% | 105,075 | 增持 |
| 11 | CAH | Cardinal Health, Inc. | $15.3M | 2.33% | 171,480 | 增持 |
| 12 | UNH | UnitedHealth Group Incorporated | $14.1M | 2.15% | 120,000 | 持平 |
| 13 | SYK | Stryker Corporation | $13.1M | 1.99% | 140,700 | 持平 |
| 14 | TEVA | Teva Pharmaceuticals, Inc. | $11.6M | 1.77% | 176,720 | 增持 |
| 15 | ESRX | Express Scripts Holding Company | $10.8M | 1.65% | 124,000 | 减持 |
| 16 | ENDPQ | Endo International PLC | $10.5M | 1.60% | 171,000 | 增持 |
| 17 | EARS | Auris Medical Holding AG | $10.4M | 1.59% | 2.2M | 持平 |
| 18 | ZBH | Zimmer Holdings, Inc. | $9.8M | 1.49% | 95,500 | 持平 |
| 19 | ALXN | Alexion Pharmaceuticals, Inc. | $9.4M | 1.44% | 49,400 | 持平 |
| 20 | CVS | CVS Health Corporation | $9.4M | 1.43% | 96,200 | 增持 |
| 21 | LGND | Ligand Pharmaceuticals Incorporated | $8.9M | 1.35% | 81,640 | 减持 |
| 22 | INCY | Incyte Corporation | $8.6M | 1.31% | 79,000 | 增持 |
| 23 | IONS | Ionis Pharmaceuticals Inc. | $8.5M | 1.30% | 138,000 | 新建仓 |
| 24 | BSX | Boston Scientific Corporation | $8.5M | 1.29% | 460,000 | 增持 |
| 25 | JAZZ | Jazz Pharmaceuticals Public Limited Company | $8.4M | 1.29% | 60,000 | 增持 |
来源：SEC 13F 申报文件 · 截至 2015-12-31
本期 13F-HR 中的全部持仓，以及相对上季度的变化。
13F 持仓，最新季度
来源SEC EDGAR13F-HR